Some of the content on this website requires JavaScript to be enabled in your web browser to function as intended. While the website is still usable without JavaScript, it should be enabled to enjoy the full interactive experience.

Skip to Main Navigation. Each navigation link will open a list of sub navigation links.

Skip to Main Content

UW Technologies Available for LIcensing|Wyoming Research Products Center

 Modifying Insect Cell Glycosylation Pathways with Baculovirus Expression Vectors


Description of Technology:

The invention first provides a baculovirus expression vector characterized as either: (a) comprising at least a first and a second glycosylation enzyme transcription unit, the transcriptional units comprising a first and a second structural gene encoding a first and second oligosaccharide processing enzyme, each gene operatively positioned under the control of and in frame with a promoter; or (b) compromising at least a first glycosylation enzyme transcriptional unit, the transcriptional unit comprising a structural gene encoding an oligosaccharide processing enzyme, the gene operatively positioned under the control of a baculoviral immediate early, delayed early, early or late promoter.


The insect cells can be used for high volume, glycosylated protein production.

Features and Benefits:

This cell line has normal morphologies, growth properties and remains competent as a host for baculovirus expression vectors. The cell line offers a distinct advantage over unmodified hosts for the baculovirus-meditated production of more authentic recombinant N-glycoproteins.

For More Information Please Contact:

Davona Douglass, J.D.
(307) 766-2509

Share This Page:

Tech ID


Patent Status

Footer Navigation

University of Wyoming Medallion
1000 E. University Ave. Laramie, WY 82071 // UW Operators (307) 766-1121 // Contact Us // Download Adobe Reader // Accessibility Accessibility information icon